Olink

Olink®
Part of Thermo Fisher Scientific

Linear and non-linear proteome-wide association studies provide novel insight into venous thromboembolism

Nature Communications, 2025

Kong Y., Tang W., Kang H., Guan Y., Li S., Cao X., Shao Z., Jiang Y., Wang C., Hao X.

Disease areaApplication areaSample typeProducts
CVD
Pathophysiology
Plasma
Olink Target 96

Olink Target 96

Olink Explore 3072/384

Olink Explore 3072/384

Abstract

Venous thromboembolism is a life-threatening vascular event with high prevalence and genetic determinants. PWAS has become a popular strategy to identify therapeutic targets of complex diseases. However, the current PWAS model only considers the linear relationship between protein and disease. Here, we propose a novel non-linear PWAS pipeline and identify 43 proteins exhibiting non-linear associations with venous thromboembolism in the UK Biobank, of which eight proteins cannot be captured by linear PWAS. We further conduct prospective cohort replication in the UK Biobank Pharma Proteomics Project, and replicate eight proteins with similar non-linear trends, including ULBP2, IL18BP, MAN1A2, CCL25, ICAM2, LGALS4, VSIG2 and ABO. Pathway enrichment analysis suggests that the identified non-linear proteins are involved in endothelium development, fluid shear stress and atherosclerosis pathways. In summary, we develop a novel non-linear PWAS analysis pipeline, and identify 43 non-linear proteins with venous thromboembolism, highlighting the importance of incorporating non-linear analysis in PWAS.

Read publication ↗